Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.72 |
| ▸ | HTT | P42858 | 2/20 | 0.65 |
| ▸ | LPAR5 | Q9H1C0 | 4/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | THRB | P10828 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | PLA2G2C | Q5R387 | 2/20 | 0.50 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.50 |
| ▸ | LPAR1 | Q92633 | 7/20 | 0.44 |
| ▸ | LPAR3 | Q9UBY5 | 7/20 | 0.44 |
| ▸ | LPAR2 | Q9HBW0 | 4/20 | 0.44 |
| ▸ | LPAR6 | P43657 | 3/20 | 0.44 |
| ▸ | LPAR4 | Q99677 | 3/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21046007 | 1.00 | USP2 (0.72) | USP2HTTLPAR5CYP1A2CYP3A4 | |
| SCHEMBL9716294 | 1.00 | USP2 (0.72) | USP2HTTLPAR5CYP1A2CYP3A4 | |
| SCHEMBL21046021 | 1.00 | USP2 (0.72) | USP2HTTLPAR5CYP1A2CYP3A4 | |
| SCHEMBL21046039 | 1.00 | USP2 (0.72) | USP2HTTLPAR5CYP1A2CYP3A4 | |
| SCHEMBL21046028 | 1.00 | USP2 (0.72) | USP2HTTLPAR5CYP1A2CYP3A4 | |
| SCHEMBL21046017 | 1.00 | USP2 (0.72) | USP2HTTLPAR5CYP1A2CYP3A4 | |
| SCHEMBL10435643 | 0.98 | USP2 (0.69) | USP2HTTLPAR5CYP1A2CYP3A4 | |
| SCHEMBL13966358 | 0.92 | USP2 (0.60) | USP2HTTLPAR5CYP1A2CYP3A4 | |
| SCHEMBL2853366 | 0.92 | USP2 (0.60) | USP2HTTLPAR5CYP1A2CYP3A4 | |
| SCHEMBL19257794 | 0.90 | USP2 (0.74) | USP2HTTLPAR5CYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190169218-A1 | AMPHIPATHIC COMPOUND HAVING NOVEL PENTA-SACCHARIDE HYDROPHILIC GROUP AND USE THEREOF | INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY ERICA CAMPUS (KR) | 2019-06-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190169218-A1 | AMPHIPATHIC COMPOUND HAVING NOVEL PENTA-SACCHARIDE HYDROPHILIC GROUP AND USE THEREOF | UGCG, APMAP, GID4 | USP2 3446/4885HTT 2033/4885LPAR5 2863/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.